Top Startups Series

Interview with the CEO of Regrow, one of the top companies recognized within the agriculture imagery category. For more information visit startupdealflow.com

Interview with the CEO of VIDA, one of the top companies recognized  within the healthcare imagery category.     1:04: What does VIDA do? 1:35: What is the backstory of VIDA? 2:47: When would providers use VIDA?   4:58: Why are CT scans used for respiratory exams? 6:28: What did providers do without VIDA? 8:43: Can you share more details about your patent on visualizing lungs? 10:33: How did you build your platform’s functionality?   13:44: How much assistance does your AI solution provide? 17:41: Can you talk about your supporting services that you offer to  your customers? 22:09: Are there limitations or risks using your platform? 25:37: How do you implement VIDA? 28:54: How do you manage long sales cycles? 30:50: How has the pandemic affected your company? 36:36: What is the future of healthcare imagery services? 39:16: Closing remarks   About VIDA: VIDA provides AI-powered chest CT analysis to profile/manage a patient with, or at-risk of, respiratory diseases. Their software automatically quantifies lung density and visualizes airways. They do this using a topographic MPR technique that samples/projects many non-overlapping airways onto a single image. This method delivers global airway information, at higher resolution, without losing context to the  surrounding tissue. Their platform also provides per-procedural pat  planning, intra-procedural guidance (virtual bronchoscopy), lung cancer  resection (LCR) evaluations and lung volume analysis reports. Visit: vidalung.ai

Interview with the CEO of DiA Imaging Analysis, one of the top companies recognized within the healthcare imagery category.    1:06: What does DiA do? 3:24: What is the backstory behind DiA? 5:58: Why did you focus on ultrasound? 8:47: Are you providing software, hardware or both? 12:00: How did you build your AI solutions? 16:03: How far do you go with assisting providers? 20:53: How do you manage long sales cycles? How has the pandemic affected your company? 24:06: Closing remarks   About: DiA Imaging Analysis provides AI-powered cardiac ultrasound analysis solutions. Visit: https://www.dia-analysis.com/

Interview with the VP Marketing at Circle Cardiovascular Imaging, one of the top companies recognized within the healthcare imagery category.    1:10: What does Circle Cardiovascular Imaging do? 3:55: What’s the backstory of Circle Cardiovascular Imaging? 5:25: Most of your features revolve around quantifying heart structures -  why is this important? 7:33: How did you build the functionality of your platform? 10:21: Is your platform making diagnosis? 12:15: Why is providing 3D models of the heart important? 14:57: Why is measuring exact blood flow from MR scans important? 17:29: What did providers do without your platform? 19:24: What does that workflow look like for providers? 22:36: What is your implementation process? 26:20: Are you making diagnosis? 29:15: Do providers prefer to have guided workflows or just data? 30:23: What do the new AI assist features do? 32:54: What does the AI assist tool look like to a provider? 35:13: How do providers physically interact with Circle Cardiovascular Imaging? 37:35: How do you manage long sales cycles? 40:09: How have you managed to grow internationally? 42:22: What deliverables resonate with your customers? 43:33: What is the business model? What is the market size for cardiovascular imagery?   47:35: How has the pandemic affected your company? 49:35: What is the future healthcare imagery services? 51:35: Closing remarks

Interview with Qidong Jia, Partner at CentreGold Capital, one of the top investors recognized within the healthcare industry.    1:03​ Who is CentreGold Capital? 3:48​ Why did you focus on a select few areas of healthcare? 7:22​ Are you looking for moonshots or something practical as an early stage healthcare investor? 11:10​ Do you focus on platform plays or tools for specific conditions? 16:20​ Can you highlight some of your investments? 21:47​ How do you know the right tool to manage a specific health issue? 27:03​ Healthcare has long sales cycles - how does this shape your investment thesis? 31:22​ How does the pandemic change your outlook on healthcare? 34:50​ Are there any healthcare technology companies you’re excited about? 37:16​ Highlighting unique features of Catalyst Health Ventures - portfolio development 39:24​ Closing Remarks   About CentreGold Capital: CentreGold Capital invests in early-stage consumer marketplaces and digital health startups in North America and China. We back visionary entrepreneurs with innovative solutions to improve quality of life. Being sector-focused enables us to support our portfolio companies within an ecosystem. Visit: www.centregoldcap.com

Interview with the CEO of Arterys, one of the top companies recognized within the healthcare imagery category. 1:00: What does Arterys do? 8:58: What is the backstory of Arterys? 11:00: What imagery use case did you choose to start with? 12:11: Can you explain cardiovascular AI imagery features and how they change provider workflows? 16:53: How did you build this platform? Where did data come from? Are there limitations? 19:57: Can you explain chest CT AI imagery features? 23:51: How did you build this functionality for CT imagery analysis?   25:35: Can you explain your X-Ray AI assist? 29:17: Are there any other applications providers can do using your current tools? 31:22: Why are you expanding into multiple imagery verticals? 36:02: What is your relationship with the vendors in your marketplace? 38:32: How do you implement Arterys? 43:13: What level of assistance do you provide to radiologists? 45:55: Why do you have 7 FDA clearances? 47:30: How do you manage healthcare long sales cycles? 49:22: What deliverables resonate with your customers? 51:31: What is your business model? 53:00: What is the market size for imagery? 55:27: What is the future of imagery services? 57:43: How has the pandemic affected your company? 59:22: Closing Remarks

Interview with the Chief Medical Officer at SpringTide Ventures, one of the top investors recognized within the healthcare industry.   0:50​ Who is Springtide Ventures? 2:07​ What is your background? 4:40​ What is AI healthcare investing? 7:12​ Healthcare is so vast, how do you filter this industry? 11:11​ Are you looking for moonshots or something practical as an early stage healthcare investor? 14:25​ What do you see in healthcare most people don’t? 17:19​ Can it be limiting to invest in healthcare? 18:40​ Can you highlight some of your investments? 24:17​ Healthcare has long sales cycles - how does this shape your investment thesis? 28:22​ How do you know the right tool to manage a specific health issue? 31:54​ Do you focus on platform plays or tools for specific conditions? 33:25​ How does the pandemic change your outlook on healthcare? 38:11​ Highlighting unique features of Springtide Ventures - portfolio development and sales network. 41:42​ Closing Remarks   About SpringTide Ventures: SpringTide is a network of experienced healthcare founders, operators, and investors in the healthcare space. With over $350M in collective exits across 4 startup companies, our Managing Partners are driven to provide access and support for fellow entrepreneurs who are expanding access to quality healthcare. Visit: www.springtideinvestments.com

Interview with the CEO of Healint, one of the top companies recognized within the healthcare health management category.    0:55​ What does Healint do? 2:23​ What’s the background story of Healint? 6:52​ Why did you focus on migraines first? 13:36​ Why did you choose to focus on D2C? 19:53​ What type of patients are using your platform? 25:32​ How did you build your prediction models and treatment recommendations? 31:03​ How are you able to detect upcoming attacks? 36:26​ You’ve built a 10M patient registry, what’s its purpose? 41:26​ Can you talk about some of the applications you’ve built off of your patient registry? 44:02​ How do you plan to expand outside of Migraine? 47:23​ What is the future of health management? 52:56​ Closing remarks   About Healint: Healint provides a migraine and headache health tracker. Users can track/find patterns, participate in crowdsourced learnings, predict risks/anticipate attacks, find the best reliefs, view coaching plans, record sleep, generate attack reports and more. Visit: healint.com About Top Startups Summit: The Top Startups Summit was created to recognize the top startups in a specific industries globally. We've spent months mapping industries, selecting the top companies and writing detailed reports on the best technologies. We have hosted many investor-only events to discuss industry trends. Now we're opening our work to the public. We will share the list of all the top startups per industry, a lengthy due diligence report and we'll invite the best founders & investors on stage to share unique insights you won't find anywhere else.... all for free.  Visit: TopStartupsSummit.com

Interview with Amit Aysola, Managing Director at Wanxiang Healthcare Investments, one of the top investors recognized within the healthcare industry.    0:51​ Who is Wanxiang Healthcare Investments? 3:36​ What is your healthcare investment thesis? 7:10​ Healthcare is so vast, how do you filter this industry? 11:07​ Are you looking for moonshots or something practical as an early stage healthcare investor? 17:10​ What do you see in healthcare most people don’t? 21:47​ Can it be limiting to invest in healthcare? 24:00​ Can you highlight some of your investments? 32:11​ How do you know the right tool to manage a specific health issue? 34:43​ Do you focus on platform plays or tools for specific conditions? 40:00​ Healthcare has long sales cycles - how does this shape your investment thesis? 43:00​ What is the business model that works for the health management category? 47:30​ How does the pandemic change your outlook on healthcare? 51:00​ Highlighting unique features of Wanxiang Healthcare Investments - very flexible. 54:40​ Closing Remarks   About Wanxiang Healthcare Investments: Wanxiang Healthcare Investments is the venture capital arm of Wanxiang America Corporation. They invest in innovative, early to growth stage companies and target opportunities in Health IT.  Visit: www.wanxianghealthcare.com   About Top Startups Summit: The Top Startups Summit was created to recognize the top startups in a specific industries globally. We've spent months mapping industries, selecting the top companies and writing detailed reports on the best technologies. We have hosted many investor-only events to discuss industry trends. Now we're opening our work to the public. We will share the list of all the top startups per industry, a lengthy due diligence report and we'll invite the best founders & investors on stage to share unique insights you won't find anywhere else.... all for free.  Visit: TopStartupsSummit.com

Interview with the CEO of Sweetch, one of the top companies recognized within the healthcare health management category.    1:20​ What does Sweetch do? 3:48​ What is the backstory of Sweetch? 9:24​ Why did you focus on chronic conditions? 13:09​ How does Sweetch collect data and create personalized care plans? 23:55​ What keeps patient engaged long term? 32:06​ What is your business model? 36:47​ How has the pandemic affected your company? 39:30​ What is the future of chronic care management is going? 44:39​ Closing Remarks   About Sweetch: Sweetch provides an AI-based digital personal intervention program for different chronic disease conditions including metabolic disease, cardiovascular and autoimmune. Sweetch's platform guides users to achieving their goals relating to weight, activity, healthy nutrition/habits, medication adherence, and treatment protocols. This platform automatically turns data points from a user's smartphone, connected devices and surveys, into personalized recommendations. These recommendations continuously adapt to the user's personal, environmental and behavioral preferences. They also provide a customized web-based management dashboard for providers to view patients data, it can predict chronic disease and engage users to keep them on track with their health goals. Visit: sweetch.com